Sirona Biochem Corp. Stock
Your prediction
Pros and Cons of Sirona Biochem Corp. in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sirona Biochem Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sirona Biochem Corp. | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -5.240% | 15.640% | 16.746% | -13.628% | 20.792% | 163.784% | - |
| Larimar Therapeutics Inc. | -1.400% | -3.425% | -16.071% | -21.667% | -15.060% | -26.943% | -83.174% |
| Vaxart Inc. | 24.240% | 50.735% | 46.429% | -47.503% | 46.429% | -54.545% | -92.407% |
Comments
News
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Dentsply Sirona (NASDAQ:XRAY), a major player in dental products and technologies, released its second quarter results on August 7, 2025. The company reported GAAP revenue of $936 million and
